SEC Form 4 Filing for Michael Catelani

This SEC Form 4 filing reports a transaction by Michael Catelani, President, COO, and CFO of Anixa Biosciences Inc. On September 30, 2026, Catelani acquired 5,500 shares of Anixa Biosciences common stock at a price of $2.84 per share. Following this transaction, Catelani directly owns 50,000 shares of the company's common stock. The transaction code "P" indicates a "Purchase" and the code "A" signifies an "Acquisition". This filing is made pursuant to Section 16 of the Securities Exchange Act of 1934, which requires insider reporting of stock transactions.